KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maxlinear (MXL) EBT Margin (2016 - 2025)

Maxlinear (MXL) has disclosed EBT Margin for 16 consecutive years, with 13.05% as the latest value for Q4 2025.

  • On a quarterly basis, EBT Margin rose 3124.0% to 13.05% in Q4 2025 year-over-year; TTM through Dec 2025 was 30.13%, a 3608.0% increase, with the full-year FY2025 number at 30.13%, up 3608.0% from a year prior.
  • EBT Margin was 13.05% for Q4 2025 at Maxlinear, up from 34.31% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 17.06% in Q1 2022 to a low of 101.72% in Q3 2024.
  • A 5-year average of 18.52% and a median of 8.3% in 2021 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: plummeted -8785bps in 2024, then soared 6741bps in 2025.
  • Maxlinear's EBT Margin stood at 11.49% in 2021, then grew by 22bps to 14.01% in 2022, then tumbled by -343bps to 34.01% in 2023, then tumbled by -30bps to 44.29% in 2024, then surged by 71bps to 13.05% in 2025.
  • Per Business Quant, the three most recent readings for MXL's EBT Margin are 13.05% (Q4 2025), 34.31% (Q3 2025), and 28.21% (Q2 2025).